Join us for a high high-level roundtable and B2B networking session spotlighting Ghana and Senegal – two countries at the forefront of pharmaceutical manufacturing in West Africa, a growing market of more than 450 million people. With Senegal and Ghana both achieving WHO Maturity Level 3 and fostering conducive environments for local manufacturing, now is the time to engage.
30 October 2025
14.00 – 17.00 CET
GIZ Eschborn
Building 3, Room ED30016-18
Dag-Hammarskjöld-Weg 1 1-5, 65760 Eschborn (near Frankfurt/Germany)
With co-financing from the EU and German Cooperation (BMZ), GIZ supports pharmaceutical and vaccine manufacturing in Ghana and Senegal under the Team Europe Initiative on Manufacturing and Access to Vaccines, Medicines and Health Technologies in Africa (MAV+). The session is organised by GIZ in partnership with pharmaceutical and private sector associations from Ghana, Senegal and Germany.
The event is free of charge, but space is limited! Register now, to secure your place:
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH
Bonn and Eschborn, Germany
GIZ – PharmaVax Ghana
Dr. Holger Till
Capital Place (Block A), 11 Patrice Lumumba Road
Airport residential area – Accra – Ghana
GIZ – SenPharm
Rozenn Le Mentec
Rond-Point Ngor Almadies Zone 15,
B.P. 3869 – Dakar – Senegal
PharmaVaxGH@giz.de
vorstand@african-german-health-association.de
GIZ, Madeleine Schön
This event is organised with the financial support of the European Union (EU) and the German Federal Ministry for Economic Cooperation and Development (BMZ). Its contents are the sole responsibility of GIZ and do not necessarily reflect the views of the EU or the BMZ.